Abstract
Aims: To test the diagnostic potential of a hand-held ultrasound device for screening for left ventricular hypertrophy in a hypertensive population using a standard echocardiographic system as a reference. Methods: One hundred consecutive hypertensive patients were enrolled. An experienced investigator performed measurements of the thickness of the anterior septum and posterior wall using the parasternal 2D-long axis view and the end-diastolic dimension of the left ventricle with both imaging devices. Left ventricular hypertrophy was defined as an increase in left ventricular mass ≥ 134 g. m-2 for men and ≥ 110 g. m-2 for women, when indexed for body surface area and ≥ 143 g. m-1 for men and ≥ 102 g. m-1 for women, when indexed for height. Results: Sixty-five men and 35 women were studied (age 60 ± 11 years); mean duration of hypertension: 13 ± 11 years; mean blood pressures: systolic 150 ± 20 mmHg and diastolic 89 ± 11 mmHg. The anterior septum and posterior wall were visualized in all patients with both imaging devices. The standard echocardiographic system identified left ventricular hypertrophy by body surface area in 18 (18%) patients and by height in 26 (26%) patients. The agreement between the standard echocardiographic system and the hand-held device for the assessment of left ventricular hypertrophy was 93%, kappa: 0.77 (left ventricular mass/body surface area) and 90%, kappa: 0.76 (left ventricular mass/height). Conclusions: We conclude that hand-held devices can be effectively applied for screening for left ventricular hypertrophy in hypertensive patients.
| Original language | English |
|---|---|
| Pages (from-to) | 1516-1521 |
| Number of pages | 6 |
| Journal | European Heart Journal |
| Volume | 23 |
| Issue number | 19 |
| DOIs | |
| Publication status | Published - Oct 2002 |
Fingerprint
Keywords
- Hand-held ultrasound device
- Left ventricular hypertrophy
- Left ventricular mass
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Left ventricular hypertrophy screening using a hand-held ultrasound device. / Vourvouri, E. C.; Poldermans, Don; Schinkel, A. F L; Koroleva, L. Y.; Sozzi, F. B.; Parharidis, G. E.; Bax, J. J.; Roelandt, J. R T C.
In: European Heart Journal, Vol. 23, No. 19, 10.2002, p. 1516-1521.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Left ventricular hypertrophy screening using a hand-held ultrasound device
AU - Vourvouri, E. C.
AU - Poldermans, Don
AU - Schinkel, A. F L
AU - Koroleva, L. Y.
AU - Sozzi, F. B.
AU - Parharidis, G. E.
AU - Bax, J. J.
AU - Roelandt, J. R T C
PY - 2002/10
Y1 - 2002/10
N2 - Aims: To test the diagnostic potential of a hand-held ultrasound device for screening for left ventricular hypertrophy in a hypertensive population using a standard echocardiographic system as a reference. Methods: One hundred consecutive hypertensive patients were enrolled. An experienced investigator performed measurements of the thickness of the anterior septum and posterior wall using the parasternal 2D-long axis view and the end-diastolic dimension of the left ventricle with both imaging devices. Left ventricular hypertrophy was defined as an increase in left ventricular mass ≥ 134 g. m-2 for men and ≥ 110 g. m-2 for women, when indexed for body surface area and ≥ 143 g. m-1 for men and ≥ 102 g. m-1 for women, when indexed for height. Results: Sixty-five men and 35 women were studied (age 60 ± 11 years); mean duration of hypertension: 13 ± 11 years; mean blood pressures: systolic 150 ± 20 mmHg and diastolic 89 ± 11 mmHg. The anterior septum and posterior wall were visualized in all patients with both imaging devices. The standard echocardiographic system identified left ventricular hypertrophy by body surface area in 18 (18%) patients and by height in 26 (26%) patients. The agreement between the standard echocardiographic system and the hand-held device for the assessment of left ventricular hypertrophy was 93%, kappa: 0.77 (left ventricular mass/body surface area) and 90%, kappa: 0.76 (left ventricular mass/height). Conclusions: We conclude that hand-held devices can be effectively applied for screening for left ventricular hypertrophy in hypertensive patients.
AB - Aims: To test the diagnostic potential of a hand-held ultrasound device for screening for left ventricular hypertrophy in a hypertensive population using a standard echocardiographic system as a reference. Methods: One hundred consecutive hypertensive patients were enrolled. An experienced investigator performed measurements of the thickness of the anterior septum and posterior wall using the parasternal 2D-long axis view and the end-diastolic dimension of the left ventricle with both imaging devices. Left ventricular hypertrophy was defined as an increase in left ventricular mass ≥ 134 g. m-2 for men and ≥ 110 g. m-2 for women, when indexed for body surface area and ≥ 143 g. m-1 for men and ≥ 102 g. m-1 for women, when indexed for height. Results: Sixty-five men and 35 women were studied (age 60 ± 11 years); mean duration of hypertension: 13 ± 11 years; mean blood pressures: systolic 150 ± 20 mmHg and diastolic 89 ± 11 mmHg. The anterior septum and posterior wall were visualized in all patients with both imaging devices. The standard echocardiographic system identified left ventricular hypertrophy by body surface area in 18 (18%) patients and by height in 26 (26%) patients. The agreement between the standard echocardiographic system and the hand-held device for the assessment of left ventricular hypertrophy was 93%, kappa: 0.77 (left ventricular mass/body surface area) and 90%, kappa: 0.76 (left ventricular mass/height). Conclusions: We conclude that hand-held devices can be effectively applied for screening for left ventricular hypertrophy in hypertensive patients.
KW - Hand-held ultrasound device
KW - Left ventricular hypertrophy
KW - Left ventricular mass
UR - http://www.scopus.com/inward/record.url?scp=0036800365&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036800365&partnerID=8YFLogxK
U2 - 10.1053/euhj.2002.3162
DO - 10.1053/euhj.2002.3162
M3 - Article
C2 - 12242071
AN - SCOPUS:0036800365
VL - 23
SP - 1516
EP - 1521
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 19
ER -